Caremark to settle claims
Seattle Post-Intelligencer, February 15, 2008
Pharmacy benefits manager Caremark has agreed to pay Washington nearly $1.7 million as part of a $41 million multistate settlement of claims that it encouraged doctors to switch patients' prescriptions while representing that the switch would save patients money. In some cases, the patients or their health plans ended up paying more. And sometimes patients incurred more costs when they switched, because new drug therapies required additional tests or doctor's visits, according to the state's complaint. Caremark got rebates and discounts from drug manufacturers for switching patients to different drugs and didn't clearly disclose how it would affect a patient's cost, the state alleged. Caremark denied any wrongdoing but agreed to change its business practices.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers